Effect of indomethacin,diclofenac or naproxen on prevention of pancreatitis
Phase 4
- Conditions
- pancreatitis.Other acute pancreatitis
- Registration Number
- IRCT2014100111192N3
- Lead Sponsor
- Deputy of Research, School of Pharmacy, Shahid Beheshti Universty of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 180
Inclusion Criteria
Patients undergoing ERCP in Taleghani hospital by taking written consent
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pancreatitis. Timepoint: 10 days after doing ERCP. Method of measurement: clinical evaluation.
- Secondary Outcome Measures
Name Time Method Gastrointestinal bleeding. Timepoint: 10 days after doing ERCP. Method of measurement: clinical evaluation.;Hypersensitivity reactions. Timepoint: 10 days after doing ERCP. Method of measurement: Clinical observation.